Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Gains from Investment Securities (2016 - 2026)

Gyre Therapeutics has reported Gains from Investment Securities over the past 16 years, most recently at -$2000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities fell 100.1% to -$2000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, up 177.79% year-over-year, with the annual reading at $19.5 million for FY2025, 7.77% up from the prior year.
  • Gains from Investment Securities was -$2000.0 for Q4 2025 at Gyre Therapeutics, down from $23000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $18.5 million in Q3 2024 and troughed at -$5.3 million in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $1.7 million (2022), against an average of $3.9 million.
  • Year-over-year, Gains from Investment Securities tumbled 1026.13% in 2024 and then skyrocketed 954341.26% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $2.6 million in 2021, then surged by 554.35% to $17.0 million in 2022, then plummeted by 131.02% to -$5.3 million in 2023, then surged by 139.45% to $2.1 million in 2024, then tumbled by 100.1% to -$2000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Gains from Investment Securities are -$2000.0 (Q4 2025), $23000.0 (Q3 2025), and $17.8 million (Q2 2025).